Center for U.S. PolicyCenter for U.S. Policy
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships

X the X Waiver

Federal Gov’t Expands Access to Buprenorphine for OUD

News January 14, 2021

DATA 2000 Stymies Access for Black Patients

News October 23, 2020

Congress Should Pass MAT Act To Save Lives

Third-Party Opinion August 9, 2020

Pharmacy Dispensing of Methadone for OUD Would Improve Access, Reduce Costs

News July 20, 2020

Pandemic Provides Avenue for Deregulation of OUD Treatment

Third-Party Opinion May 28, 2020

Methadone Deregulation Should Continue Post-Pandemic

Third-Party Opinion May 24, 2020

Coronavirus Compels Us To Reconsider X Waiver

Third-Party Opinion April 7, 2020

COVID-19: OUD Practice and Policy Considerations

Third-Party Opinion April 3, 2020

Pandemic Highlights Need for OUD Treatment Reform

Third-Party Opinion March 17, 2020

Let’s Ease Restrictions on Buprenorphine for OUD

Third-Party Opinion March 5, 2020
Loading...
Print page

© 2021 Center for U.S. Policy. All Rights Reserved.